Livforsakringsbolaget Skandia, Omsesidigt Regeneron Pharmaceuticals, Inc. Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 11,432 shares of REGN stock, worth $8.02 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

11,432

Previous 8,532 33.99%

Holding current value

$8.02 Million

Previous $8.97 Million 34.01%

% of portfolio

0.7%

Previous 0.73%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$1024.09 - $1201.76 $2.97 Million - $3.49 Million	2,900 Added 33.99%	11,432 $12 Million
Q2 2024 Jul 15, 2024	SELL	$883.2 - $1071.19 $88,320 - $107,119	-100 Reduced 1.16%	8,532 $8.97 Million
Q4 2023 Jan 31, 2024	BUY	$775.18 - $881.7 $91,471 - $104,040	118 Added 1.39%	8,632 $7.58 Million
Q3 2023 Oct 20, 2023	SELL	$692.45 - $844.37 $276,980 - $337,748	-400 Reduced 4.49%	8,514 $7.01 Million
Q2 2023 Jul 06, 2023	SELL	$700.03 - $830.35 $630,027 - $747,315	-900 Reduced 9.17%	8,914 $6.41 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $15,529 - $16,860	-22 Reduced 0.22%	9,814 $7.08 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $975,749 - $1.23 Million	-1,700 Reduced 14.74%	9,836 $6.78 Million
Q2 2022 Aug 16, 2022	SELL	$548.35 - $738.84 $109,670 - $147,768	-200 Reduced 1.7%	11,536 $6.82 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $989,133 - $1.22 Million	1,820 Added 18.35%	11,736 $7.41 Million
Q3 2021 Oct 28, 2021	BUY	$574.03 - $680.96 $1.5 Million - $1.78 Million	2,610 Added 35.72%	9,916 $6 Million
Q2 2021 Jul 13, 2021	BUY	$472.8 - $558.54 $189,120 - $223,416	400 Added 5.79%	7,306 $4.08 Million
Q1 2021 May 07, 2021	BUY	$446.73 - $548.2 $357,384 - $438,560	800 Added 13.1%	6,906 $3.27 Million
Q4 2020 Mar 02, 2021	BUY	$478.3 - $607.98 $286,980 - $364,788	600 Added 10.9%	6,106 $2.95 Million
Q3 2020 Nov 09, 2020	BUY	$544.75 - $658.21 $305,060 - $368,597	560 Added 11.32%	5,506 $3.08 Million
Q2 2020 Jul 08, 2020	BUY	$493.32 - $643.92 $922,508 - $1.2 Million	1,870 Added 60.79%	4,946 $3.09 Million
Q1 2020 Apr 22, 2020	BUY	$336.18 - $494.43 $100,854 - $148,329	300 Added 10.81%	3,076 $1.5 Million
Q4 2019 Jan 28, 2020	SELL	$274.13 - $376.51 $109,652 - $150,604	-400 Reduced 12.59%	2,776 $1.04 Million
Q3 2019 Oct 29, 2019	BUY	$273.46 - $318.39 $218,767 - $254,712	800 Added 33.67%	3,176 $881,000
Q2 2019 Jul 19, 2019	BUY	$299.6 - $414.82 $479,360 - $663,712	1,600 Added 206.19%	2,376 $743,000
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $37,208 - $43,957	100 Added 14.79%	776 $319,000
Q3 2018 Oct 26, 2018	SELL	$351.14 - $408.51 $280,912 - $326,808	-800 Reduced 54.2%	676 $273,000
Q2 2018 Jul 10, 2018	BUY	$284.6 - $344.99 $85,380 - $103,497	300 Added 25.51%	1,476 $509,000
Q4 2017 Jan 18, 2018	SELL	$358.63 - $469.95 $107,589 - $140,985	-300 Reduced 20.33%	1,176 $442,000
Q3 2017 Oct 12, 2017	BUY	$431.38 - $504.0 $636,716 - $743,904	1,476	1,476 $660,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Regeneron Pharmaceuticals, Inc. Transaction History